Biotechnology
The Biotechnology industry has a total of 595 stocks, with a combined market cap of $1.37 trillion and total revenue of $115.78 billion.
Market Cap
1.37T
Revenue
115.78B
Profits
-39.71B
PE Ratio
n/a
Profit Margin
-34.29%
Dividend Yield
0.04%
595 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 136.97B | -2.11% | 387,632 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 83.39B | -0.69% | 253,576 | 15.53B |
| 3 | ARGX | argenx SE | 64.66B | -0.20% | 165,204 | 5.32B |
| 4 | MRNA | Moderna, Inc. | 53.30B | -23.44% | 78,564,833 | 2.23B |
| 5 | RVMD | Revolution Medicines, Inc. | 45.32B | -1.50% | 734,992 | - |
| 6 | ONC | BeOne Medicines AG | 42.39B | -1.08% | 104,201 | 6.13B |
| 7 | RPRX | Royalty Pharma plc | 34.98B | -1.46% | 1,765,653 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.92B | -4.76% | 968,348 | 4.80B |
| 9 | BNTX | BioNTech SE | 28.03B | -1.35% | 2,724,437 | 3.03B |
| 10 | INSM | Insmed Incorporated | 27.52B | -3.54% | 917,509 | 1.14B |
| 11 | ROIV | Roivant Sciences Ltd. | 26.68B | -1.26% | 1,486,605 | 7.53M |
| 12 | INCY | Incyte Corporation | 25.94B | -0.37% | 536,522 | 5.82B |
| 13 | GMAB | Genmab A/S | 19.98B | -1.70% | 4,279,055 | 4.13B |
| 14 | ASND | Ascendis Pharma A/S | 16.83B | -1.28% | 331,323 | 1.20B |
| 15 | BBIO | BridgeBio Pharma, Inc. | 16.24B | -1.07% | 1,216,816 | 713.07M |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 16.04B | -2.02% | 202,896 | 4.60B |
| 17 | EXEL | Exelixis, Inc. | 13.36B | -0.86% | 906,204 | 2.44B |
| 18 | BMRN | BioMarin Pharmaceutical Inc. | 13.14B | -2.09% | 521,142 | 3.41B |
| 19 | CORT | Corcept Therapeutics Incorporated | 13.00B | 1.01% | 418,655 | 830.81M |
| 20 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.26B | -2.94% | 486,141 | 669.50M |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.15B | -2.68% | 136,349 | 1.28B |
| 22 | HALO | Halozyme Therapeutics, Inc. | 12.09B | -1.00% | 702,841 | 1.66B |
| 23 | TECH | Bio-Techne Corporation | 11.28B | -0.14% | 2,072,823 | 1.22B |
| 24 | AXSM | Axsome Therapeutics, Inc. | 10.86B | -5.02% | 285,860 | 776.57M |
| 25 | CYTK | Cytokinetics, Incorporated | 10.70B | -0.95% | 954,570 | 67.67M |
| 26 | ABVX | ABIVAX Société Anonyme | 10.38B | -2.50% | 639,686 | 5.67M |
| 27 | PRAX | Praxis Precision Medicines, Inc. | 10.20B | -5.41% | 272,044 | 7.46M |
| 28 | KYMR | Kymera Therapeutics, Inc. | 10.19B | -3.74% | 287,376 | 105.00M |
| 29 | APGE | Apogee Therapeutics, Inc. | 10.17B | 0.06% | 888,208 | - |
| 30 | KRYS | Krystal Biotech, Inc. | 9.96B | -2.02% | 79,056 | 440.48M |
| 31 | SMMT | Summit Therapeutics Inc. | 9.91B | -5.26% | 3,668,795 | - |
| 32 | IONS | Ionis Pharmaceuticals, Inc. | 9.76B | -3.36% | 940,656 | 874.09M |
| 33 | PTGX | Protagonist Therapeutics, Inc. | 9.66B | -3.60% | 252,464 | 281.99M |
| 34 | SYRE | Spyre Therapeutics, Inc. | 9.41B | -2.04% | 356,278 | - |
| 35 | PCVX | Vaxcyte, Inc. | 9.16B | -2.73% | 386,049 | - |
| 36 | IMVT | Immunovant, Inc. | 9.14B | -1.53% | 488,522 | - |
| 37 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.98B | 0.01% | 8,753,724 | 42.16M |
| 38 | IBRX | ImmunityBio, Inc. | 8.36B | -2.95% | 4,869,917 | 165.79M |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.51B | -5.72% | 329,646 | 239.92M |
| 40 | TGTX | TG Therapeutics, Inc. | 7.25B | -1.14% | 1,636,884 | 799.54M |
| 41 | ORKA | Oruka Therapeutics, Inc. | 7.02B | -3.36% | 390,888 | - |
| 42 | CAI | Caris Life Sciences, Inc. | 6.96B | 8.26% | 3,751,860 | 989.61M |
| 43 | CGON | CG Oncology, Inc. | 6.89B | -3.67% | 346,582 | 6.23M |
| 44 | SRRK | Scholar Rock Holding Corporation | 6.73B | -2.18% | 635,415 | - |
| 45 | BLTE | Belite Bio, Inc | 6.50B | -4.29% | 104,269 | - |
| 46 | MIRM | Mirum Pharmaceuticals, Inc. | 6.33B | -4.60% | 157,622 | 618.07M |
| 47 | COGT | Cogent Biosciences, Inc. | 6.13B | -4.18% | 1,090,656 | - |
| 48 | TVTX | Travere Therapeutics, Inc. | 6.10B | -1.96% | 581,563 | 591.33M |
| 49 | DNTH | Dianthus Therapeutics, Inc. | 6.09B | -4.19% | 359,202 | 1.90M |
| 50 | DFTX | Definium Therapeutics, Inc. | 6.05B | -1.79% | 1,062,827 | - |
| 51 | ERAS | Erasca, Inc. | 5.97B | -5.48% | 1,526,210 | - |
| 52 | PTCT | PTC Therapeutics, Inc. | 5.92B | -3.74% | 417,860 | 1.01B |
| 53 | XENE | Xenon Pharmaceuticals Inc. | 5.78B | -4.19% | 295,000 | 7.50M |
| 54 | LGND | Ligand Pharmaceuticals Incorporated | 5.73B | -1.13% | 70,763 | 290.54M |
| 55 | CRSP | CRISPR Therapeutics AG | 5.62B | -2.78% | 2,079,118 | 13.39M |
| 56 | ACAD | ACADIA Pharmaceuticals Inc. | 5.02B | -3.51% | 563,581 | 1.14B |
| 57 | PBLS | Parabilis Medicines, Inc. | 4.92B | -3.56% | 127,203 | 148.00K |
| 58 | DYN | Dyne Therapeutics, Inc. | 4.80B | -4.07% | 747,461 | - |
| 59 | EWTX | Edgewise Therapeutics, Inc. | 4.74B | -6.08% | 410,496 | - |
| 60 | CELC | Celcuity Inc. | 4.48B | -2.30% | 279,194 | - |
| 61 | MANE | Veradermics, Incorporated | 4.37B | -5.98% | 477,350 | - |
| 62 | RLAY | Relay Therapeutics, Inc. | 4.29B | -5.54% | 1,648,347 | 10.35M |
| 63 | ELVN | Enliven Therapeutics, Inc. | 4.22B | -2.95% | 440,046 | - |
| 64 | TLX | Telix Pharmaceuticals Limited | 4.20B | 2.56% | 260,575 | 890.79M |
| 65 | LEGN | Legend Biotech Corporation | 4.11B | -5.93% | 1,518,687 | 1.27B |
| 66 | IOVA | Iovance Biotherapeutics, Inc. | 4.03B | 11.26% | 26,323,300 | 324.97M |
| 67 | VKTX | Viking Therapeutics, Inc. | 4.00B | -4.81% | 1,035,951 | - |
| 68 | DNLI | Denali Therapeutics Inc. | 3.98B | -3.04% | 495,048 | 3.60M |
| 69 | TNGX | Tango Therapeutics, Inc. | 3.93B | -7.58% | 978,619 | 53.81M |
| 70 | RCUS | Arcus Biosciences, Inc. | 3.80B | -1.71% | 1,111,236 | 117.00M |
| 71 | ABCL | AbCellera Biologics Inc. | 3.72B | -4.33% | 4,140,723 | 66.17M |
| 72 | IDYA | IDEAYA Biosciences, Inc. | 3.71B | -1.12% | 376,482 | 234.13M |
| 73 | GPCR | Structure Therapeutics Inc. | 3.65B | -5.56% | 599,605 | - |
| 74 | QURE | uniQure N.V. | 3.36B | -0.72% | 675,092 | 18.67M |
| 75 | NAMS | NewAmsterdam Pharma Company N.V. | 3.30B | -3.33% | 359,069 | 7.12M |
| 76 | IMNM | Immunome, Inc. | 3.21B | -5.23% | 500,119 | 4.02M |
| 77 | MBX | MBX Biosciences, Inc. | 3.19B | -3.24% | 207,065 | - |
| 78 | CLDX | Celldex Therapeutics, Inc. | 3.11B | -5.01% | 631,729 | 158.00K |
| 79 | TARS | Tarsus Pharmaceuticals, Inc. | 3.10B | -3.92% | 227,049 | 606.33M |
| 80 | ARQT | Arcutis Biotherapeutics, Inc. | 3.09B | -6.97% | 1,972,142 | 463.98M |
| 81 | IRON | Disc Medicine, Inc. | 3.03B | -1.61% | 148,847 | - |
| 82 | ZLAB | Zai Lab Limited | 2.95B | -1.76% | 1,011,144 | 449.61M |
| 83 | ALMS | Alumis Inc. | 2.89B | -7.00% | 555,247 | 7.40M |
| 84 | NRIX | Nurix Therapeutics, Inc. | 2.81B | -2.45% | 544,828 | 36.77M |
| 85 | BEAM | Beam Therapeutics Inc. | 2.81B | -3.27% | 1,722,162 | 156.04M |
| 86 | ATAI | AtaiBeckley Inc. | 2.76B | 1.02% | 4,971,720 | 4.47M |
| 87 | VRDN | Viridian Therapeutics, Inc. | 2.74B | -2.62% | 397,109 | 71.13M |
| 88 | SLS | SELLAS Life Sciences Group, Inc. | 2.66B | -4.98% | 6,165,144 | - |
| 89 | TRVI | Trevi Therapeutics, Inc. | 2.62B | -2.39% | 723,725 | - |
| 90 | PGEN | Precigen, Inc. | 2.61B | 1.82% | 2,889,611 | 85.72M |
| 91 | PHVS | Pharvaris N.V. | 2.54B | -0.06% | 266,265 | - |
| 92 | NKTR | Nektar Therapeutics | 2.51B | -3.33% | 248,005 | 54.59M |
| 93 | KOD | Kodiak Sciences Inc. | 2.51B | -0.27% | 228,854 | - |
| 94 | RARE | Ultragenyx Pharmaceutical Inc. | 2.49B | -3.62% | 2,479,579 | 717.00M |
| 95 | OCUL | Ocular Therapeutix, Inc. | 2.46B | -4.69% | 1,570,438 | 52.06M |
| 96 | NUVB | Nuvation Bio Inc. | 2.39B | -6.13% | 3,515,618 | 169.90M |
| 97 | MESO | Mesoblast Limited | 2.32B | 2.16% | 215,171 | 65.38M |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 2.27B | 5.57% | 1,871,708 | 311.51M |
| 99 | URGN | UroGen Pharma Ltd. | 2.27B | -7.64% | 618,733 | 188.73M |
| 100 | KLRA | Kailera Therapeutics, Inc. | 2.27B | -4.48% | 354,745 | - |
| 101 | RAPP | Rapport Therapeutics, Inc. | 2.27B | -3.70% | 101,475 | 20.00M |
| 102 | MLYS | Mineralys Therapeutics, Inc. | 2.26B | -5.01% | 384,171 | - |
| 103 | NBTX | Nanobiotix S.A. | 2.25B | -4.06% | 110,266 | 38.27M |
| 104 | COAG | Hemab Therapeutics Holdings, Inc. | 2.23B | -7.50% | 232,222 | - |
| 105 | HRMY | Harmony Biosciences Holdings, Inc. | 2.22B | -4.43% | 327,619 | 959.90M |
| 106 | VERA | Vera Therapeutics, Inc. | 2.22B | -4.49% | 900,195 | - |
| 107 | ADMA | ADMA Biologics, Inc. | 2.20B | -2.39% | 1,104,506 | 512.28M |
| 108 | VCEL | Vericel Corporation | 2.14B | -4.11% | 236,420 | 306.30M |
| 109 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.13B | 13.57% | 9,722,215 | 208.78M |
| 110 | BHVN | Biohaven Ltd. | 2.08B | -2.62% | 2,931,444 | - |
| 111 | GENB | Generate Biomedicines, Inc. | 2.06B | -5.60% | 590,078 | 26.48M |
| 112 | PVLA | Palvella Therapeutics, Inc. | 2.04B | -5.74% | 107,990 | - |
| 113 | XNCR | Xencor, Inc. | 2.03B | -0.58% | 591,388 | 104.97M |
| 114 | AGIO | Agios Pharmaceuticals, Inc. | 2.02B | -3.73% | 317,488 | 98.34M |
| 115 | ZBIO | Zenas BioPharma, Inc. | 2.01B | -1.34% | 646,343 | 1.00M |
| 116 | SRPT | Sarepta Therapeutics, Inc. | 1.98B | -4.76% | 1,192,841 | 1.97B |
| 117 | GHRS | GH Research PLC | 1.97B | -3.52% | 91,959 | - |
| 118 | KARD | Kardigan, Inc. | 1.96B | -4.93% | 145,352 | - |
| 119 | STOK | Stoke Therapeutics, Inc. | 1.96B | -8.20% | 430,853 | 27.59M |
| 120 | TSHA | Taysha Gene Therapies, Inc. | 1.95B | -7.00% | 887,733 | 5.49M |
| 121 | FBRX | Forte Biosciences, Inc. | 1.94B | - | 2,708,764 | - |
| 122 | SEPN | Septerna, Inc. | 1.90B | -7.40% | 168,928 | 98.88M |
| 123 | ZYME | Zymeworks Inc. | 1.87B | -2.90% | 150,775 | 37.13M |
| 124 | DMRA | Damora Therapeutics, Inc. | 1.87B | -6.78% | 99,139 | - |
| 125 | LKFT | Lakefront Biotherapeutics NV | 1.87B | -3.64% | 178,705 | 1.13B |
| 126 | IMCR | Immunocore Holdings plc | 1.83B | -3.80% | 242,816 | 430.78M |
| 127 | RXRX | Recursion Pharmaceuticals, Inc. | 1.78B | -5.29% | 16,476,541 | 54.86M |
| 128 | NTLA | Intellia Therapeutics, Inc. | 1.77B | -5.12% | 3,109,044 | 59.51M |
| 129 | SNDX | Syndax Pharmaceuticals, Inc. | 1.76B | -5.25% | 513,281 | 252.25M |
| 130 | BRVE | Braveheart Bio, Inc. | 1.72B | -7.32% | 119,912 | - |
| 131 | FTRE | Fortrea Holdings Inc. | 1.72B | -0.36% | 515,192 | 2.68B |
| 132 | ANAB | AnaptysBio, Inc. | 1.67B | -4.66% | 194,169 | 232.39M |
| 133 | AVLN | Avalyn Pharma Inc. | 1.64B | -5.08% | 99,436 | - |
| 134 | BCAX | Bicara Therapeutics Inc. | 1.62B | -5.28% | 210,250 | - |
| 135 | ABSI | Absci Corporation | 1.62B | -5.51% | 1,847,030 | 1.56M |
| 136 | SLBT | SL Science Holding Limited | 1.61B | 5.62% | 65,652 | 3.27M |
| 137 | MAZE | Maze Therapeutics, Inc. | 1.60B | -3.19% | 130,817 | 20.00M |
| 138 | AAPG | Ascentage Pharma Group International | 1.58B | -4.24% | 11,813 | 94.61M |
| 139 | TRAX | First Tracks Biotherapeutics, Inc. | 1.55B | -4.97% | 281,717 | - |
| 140 | TYRA | Tyra Biosciences, Inc. | 1.54B | -3.77% | 137,516 | - |
| 141 | VIR | Vir Biotechnology, Inc. | 1.54B | -6.96% | 417,671 | 303.23M |
| 142 | LBRX | LB Pharmaceuticals Inc | 1.53B | -3.15% | 111,501 | - |
| 143 | INVA | Innoviva, Inc. | 1.52B | -1.82% | 258,244 | 440.00M |
| 144 | INBX | Inhibrx Biosciences, Inc. | 1.45B | -2.86% | 165,698 | 1.30M |
| 145 | AVBP | ArriVent BioPharma, Inc. | 1.43B | -3.06% | 235,354 | - |
| 146 | ORIC | ORIC Pharmaceuticals, Inc. | 1.43B | -5.53% | 438,726 | - |
| 147 | MGTX | MeiraGTx Holdings plc | 1.40B | -2.34% | 347,833 | 397.50M |
| 148 | MNKD | MannKind Corporation | 1.37B | -2.96% | 2,164,691 | 393.63M |
| 149 | REPL | Replimune Group, Inc. | 1.37B | -1.76% | 2,717,682 | - |
| 150 | NVAX | Novavax, Inc. | 1.37B | -5.69% | 4,097,368 | 413.80M |
| 151 | VOR | Vor Biopharma Inc. | 1.36B | -2.29% | 327,342 | - |
| 152 | SVRA | Savara Inc. | 1.36B | -4.03% | 1,244,230 | - |
| 153 | CGEM | Cullinan Therapeutics, Inc. | 1.36B | -6.26% | 465,105 | - |
| 154 | JBIO | Jade Biosciences, Inc. | 1.35B | -5.76% | 589,223 | - |
| 155 | LTGO | Latigo Biotherapeutics, Inc. | 1.35B | 1.93% | 61,672 | - |
| 156 | MLTX | MoonLake Immunotherapeutics | 1.34B | -5.62% | 620,325 | - |
| 157 | ANRO | Alto Neuroscience, Inc. | 1.34B | -2.06% | 198,544 | - |
| 158 | AKTS | Aktis Oncology, Inc. | 1.33B | -4.26% | 159,068 | 10.06M |
| 159 | DRTS | Alpha Tau Medical Ltd. | 1.33B | -0.55% | 239,610 | - |
| 160 | OMER | Omeros Corporation | 1.33B | -0.44% | 896,335 | 38.42M |
| 161 | SPTX | Seaport Therapeutics, Inc. | 1.29B | -1.70% | 45,108 | - |
| 162 | GLUE | Monte Rosa Therapeutics, Inc. | 1.26B | -6.40% | 504,517 | 28.73M |
| 163 | CRVS | Corvus Pharmaceuticals, Inc. | 1.21B | -6.69% | 388,330 | - |
| 164 | IMTX | Immatics N.V. | 1.17B | -7.68% | 330,699 | 47.65M |
| 165 | APMD | Apnimed, Inc. | 1.16B | -8.77% | 340,260 | 120.15M |
| 166 | ODTX | Odyssey Therapeutics, Inc. | 1.15B | -0.87% | 82,659 | 99.00K |
| 167 | SANA | Sana Biotechnology, Inc. | 1.12B | -8.54% | 1,728,174 | - |
| 168 | IVA | Inventiva S.A. | 1.09B | -3.05% | 314,091 | 7.94M |
| 169 | JANX | Janux Therapeutics, Inc. | 1.07B | -0.34% | 461,381 | 24.00M |
| 170 | AVTX | Avalo Therapeutics, Inc. | 1.06B | -5.01% | 335,633 | 59.00K |
| 171 | KURA | Kura Oncology, Inc. | 1.04B | -6.54% | 1,259,485 | 77.23M |
| 172 | WVE | Wave Life Sciences, Inc. | 1.02B | -3.97% | 1,382,138 | 65.37M |
| 173 | GERN | Geron Corporation | 1.01B | -1.26% | 3,607,443 | 204.56M |
| 174 | LXRX | Lexicon Pharmaceuticals, Inc. | 996.70M | -7.05% | 2,331,401 | 41.47M |
| 175 | ANNX | Annexon, Inc. | 982.02M | -5.82% | 843,799 | - |
| 176 | CLYM | Climb Bio, Inc. | 981.59M | -1.44% | 466,967 | - |
| 177 | DSGN | Design Therapeutics, Inc. | 968.14M | -2.95% | 250,322 | - |
| 178 | ARDX | Ardelyx, Inc. | 965.60M | -3.85% | 2,633,199 | 450.89M |
| 179 | CADL | Candel Therapeutics, Inc. | 951.89M | -7.85% | 1,055,560 | - |
| 180 | SLDB | Solid Biosciences Inc. | 951.09M | -8.93% | 556,780 | - |
| 181 | OLMA | Olema Pharmaceuticals, Inc. | 946.72M | -4.33% | 597,866 | - |
| 182 | ABUS | Arbutus Biopharma Corporation | 946.70M | -3.92% | 680,189 | 181.72M |
| 183 | IMMX | Immix Biopharma, Inc. | 929.65M | -1.48% | 932,821 | - |
| 184 | ACRS | Aclaris Therapeutics, Inc. | 922.20M | -2.72% | 738,854 | 8.22M |
| 185 | ANL | Adlai Nortye Ltd. | 909.94M | -1.40% | 66,530 | 18.06M |
| 186 | ATTO | Attovia Therapeutics, Inc. | 908.34M | -4.65% | 228,452 | 1.35M |
| 187 | SGP | SpyGlass Pharma, Inc. | 881.69M | -3.20% | 28,348 | - |
| 188 | TBPH | Theravance Biopharma, Inc. | 880.80M | -0.15% | 86,534 | 104.31M |
| 189 | FDMT | 4D Molecular Therapeutics, Inc. | 868.99M | -6.15% | 714,744 | 92.01M |
| 190 | OBX | Obsidian Therapeutics, Inc. | 863.93M | -0.30% | 34,830 | - |
| 191 | DBVT | DBV Technologies S.A. | 861.96M | -3.45% | 78,926 | 5.04M |
| 192 | RIGL | Rigel Pharmaceuticals, Inc. | 841.90M | -4.02% | 115,556 | 276.79M |
| 193 | ACHV | Achieve Life Sciences, Inc. | 839.68M | -4.34% | 976,447 | - |
| 194 | PHAR | Pharming Group N.V. | 832.13M | -0.25% | 14,226 | 366.48M |
| 195 | FTH | Faeth Therapeutics, Inc. | 817.59M | -4.44% | 242,047 | - |
| 196 | DRUG | Bright Minds Biosciences Inc. | 814.40M | -6.30% | 85,918 | - |
| 197 | OCS | Oculis Holding AG | 807.46M | -3.61% | 58,593 | 1.45M |
| 198 | MNPR | Monopar Therapeutics Inc. | 786.60M | -5.37% | 158,163 | - |
| 199 | SLN | Silence Therapeutics plc | 786.33M | -4.04% | 273,018 | 615.00K |
| 200 | AURA | Aura Biosciences, Inc. | 786.08M | -2.70% | 296,736 | - |
| 201 | NVCT | Nuvectis Pharma, Inc. | 775.44M | 2.01% | 156,829 | - |
| 202 | HELP | Cybin Inc. | 769.22M | 5.35% | 1,085,131 | - |
| 203 | NGNE | Neurogene Inc. | 747.63M | -5.25% | 72,036 | 925.00K |
| 204 | GYRE | Gyre Therapeutics, Inc. | 740.12M | -2.38% | 38,260 | 109.82M |
| 205 | RGNX | REGENXBIO Inc. | 739.35M | -6.82% | 484,256 | 174.48M |
| 206 | STTK | Shattuck Labs, Inc. | 738.67M | -3.92% | 129,669 | 1.00M |
| 207 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 734.00M | -4.64% | 111,803 | - |
| 208 | CTMX | CytomX Therapeutics, Inc. | 723.43M | -7.00% | 1,319,771 | 18.30M |
| 209 | ALLO | Allogene Therapeutics, Inc. | 720.35M | -6.50% | 3,266,926 | 4.64M |
| 210 | TECX | Tectonic Therapeutic, Inc. | 709.74M | -1.98% | 114,913 | - |
| 211 | ZVRA | Zevra Therapeutics, Inc. | 707.85M | -1.73% | 579,565 | 136.07M |
| 212 | CBIO | Crescent Biopharma, Inc. | 695.52M | -6.18% | 45,711 | 11.88M |
| 213 | ASMB | Assembly Biosciences, Inc. | 677.91M | -1.61% | 126,754 | 74.85M |
| 214 | PHAT | Phathom Pharmaceuticals, Inc. | 671.18M | -9.33% | 857,220 | 239.66M |
| 215 | AUTL | Autolus Therapeutics plc | 665.41M | -1.57% | 2,235,126 | 117.39M |
| 216 | CRMD | CorMedix Inc. | 650.84M | -2.00% | 630,449 | 462.25M |
| 217 | PRLD | Prelude Therapeutics Incorporated | 648.87M | 9.00% | 1,191,560 | 22.42M |
| 218 | AGMB | AgomAb Therapeutics NV | 645.89M | -4.62% | 68,386 | - |
| 219 | SCTX | Scribe Therapeutics Inc. | 643.46M | 9.86% | 338,379 | 36.28M |
| 220 | VALN | Valneva SE | 641.15M | -0.03% | 23,838 | 163.30M |
| 221 | SGMT | Sagimet Biosciences Inc. | 635.88M | -3.31% | 618,234 | - |
| 222 | MDXG | MiMedx Group, Inc. | 627.50M | -3.26% | 794,977 | 355.17M |
| 223 | OABI | OmniAb, Inc. | 623.72M | 2.39% | 1,739,773 | 38.46M |
| 224 | VSTM | Verastem, Inc. | 609.94M | -7.68% | 1,451,361 | 87.53M |
| 225 | EIKN | Eikon Therapeutics, Inc. | 600.15M | -7.74% | 348,621 | - |
| 226 | CTNM | Contineum Therapeutics, Inc. | 598.18M | -0.75% | 166,611 | - |
| 227 | ARVN | Arvinas, Inc. | 596.32M | -5.79% | 355,217 | 316.70M |
| 228 | PRME | Prime Medicine, Inc. | 576.41M | -8.47% | 2,718,831 | 4.07M |
| 229 | ALT | Altimmune, Inc. | 570.91M | -5.93% | 3,219,724 | 31.00K |
| 230 | ENTX | Entera Bio Ltd. | 566.17M | 5.14% | 328,724 | 42.00K |
| 231 | SPRY | ARS Pharmaceuticals, Inc. | 561.88M | -11.44% | 1,329,924 | 116.93M |
| 232 | ZURA | Zura Bio Limited | 544.31M | -2.74% | 351,089 | - |
| 233 | ARTV | Artiva Biotherapeutics, Inc. | 539.75M | -5.64% | 186,555 | 251.00K |
| 234 | CABA | Cabaletta Bio, Inc. | 539.15M | 2.58% | 3,556,707 | - |
| 235 | OVID | Ovid Therapeutics Inc. | 535.12M | -6.48% | 652,298 | 1.58M |
| 236 | MPLT | MapLight Therapeutics, Inc. | 509.23M | -9.63% | 280,866 | - |
| 237 | KYTX | Kyverna Therapeutics, Inc. | 507.73M | -7.44% | 598,880 | - |
| 238 | BLSM | BlossomHill Therapeutics, Inc. | 487.39M | -1.64% | 135,510 | - |
| 239 | CCCC | C4 Therapeutics, Inc. | 487.18M | -5.94% | 1,498,406 | 35.04M |
| 240 | RLMD | Relmada Therapeutics, Inc. | 486.41M | -5.59% | 627,852 | - |
| 241 | RZLT | Rezolute, Inc. | 483.68M | -1.91% | 577,165 | - |
| 242 | EVMN | Evommune, Inc. | 483.41M | -11.26% | 466,147 | 10.00M |
| 243 | DNA | Ginkgo Bioworks Holdings, Inc. | 481.82M | -7.20% | 793,324 | 132.42M |
| 244 | PBYI | Puma Biotechnology, Inc. | 470.69M | -3.92% | 148,544 | 231.24M |
| 245 | OCGN | Ocugen, Inc. | 469.67M | -6.42% | 2,776,773 | 4.58M |
| 246 | EYPT | EyePoint, Inc. | 468.13M | -13.81% | 5,416,437 | 2.79M |
| 247 | QTTB | Q32 Bio Inc. | 468.12M | -0.73% | 260,541 | 53.74M |
| 248 | EPRX | Eupraxia Pharmaceuticals Inc. | 463.56M | -3.99% | 97,453 | - |
| 249 | EDIT | Editas Medicine, Inc. | 462.28M | -7.38% | 1,814,242 | 47.01M |
| 250 | PRTA | Prothena Corporation plc | 456.90M | -4.20% | 198,995 | 54.53M |
| 251 | BNTC | Benitec Biopharma Inc. | 441.11M | -4.04% | 105,135 | - |
| 252 | PROK | ProKidney Corp. | 433.83M | -3.04% | 1,139,441 | 818.00K |
| 253 | AVIR | Atea Pharmaceuticals, Inc. | 431.10M | -3.85% | 129,162 | - |
| 254 | IKT | Inhibikase Therapeutics, Inc. | 427.42M | -4.18% | 220,807 | 1.00 |
| 255 | LRMR | Larimar Therapeutics, Inc. | 424.32M | -4.35% | 662,265 | - |
| 256 | FHTX | Foghorn Therapeutics Inc. | 423.42M | 0.99% | 1,026,092 | 36.74M |
| 257 | CMPX | Compass Therapeutics, Inc. | 423.21M | -5.24% | 1,442,640 | 850.00K |
| 258 | CAPR | Capricor Therapeutics, Inc. | 410.75M | -11.47% | 5,302,026 | 11.13M |
| 259 | LXEO | Lexeo Therapeutics, Inc. | 410.21M | -6.89% | 510,378 | - |
| 260 | VTVT | vTv Therapeutics Inc. | 409.15M | 0.11% | 42,742 | 36.84M |
| 261 | XFOR | X4 Pharmaceuticals, Inc. | 398.07M | -3.49% | 372,365 | 15.85M |
| 262 | FENC | Fennec Pharmaceuticals Inc. | 397.66M | -4.47% | 133,146 | 59.22M |
| 263 | CUVL | Clinuvel Pharmaceuticals Limited | 391.00M | 10.90% | 18,072 | 64.24M |
| 264 | RCKT | Rocket Pharmaceuticals, Inc. | 379.82M | -5.21% | 564,189 | - |
| 265 | ENTA | Enanta Pharmaceuticals, Inc. | 378.34M | -3.85% | 78,601 | 65.26M |
| 266 | UPB | Upstream Bio, Inc. | 369.70M | -10.18% | 276,825 | 3.16M |
| 267 | GALT | Galectin Therapeutics Inc. | 368.10M | -0.54% | 226,149 | - |
| 268 | IPSC | Century Therapeutics, Inc. | 366.68M | -4.03% | 176,702 | 109.16M |
| 269 | ZNTL | Zentalis Pharmaceuticals, Inc. | 362.59M | 0.26% | 1,130,863 | 26.87M |
| 270 | PALI | Palisade Bio, Inc. | 358.13M | -4.86% | 898,557 | 500.00K |
| 271 | LYEL | Lyell Immunopharma, Inc. | 357.04M | -7.55% | 103,666 | 27.00K |
| 272 | DMAC | DiaMedica Therapeutics Inc. | 346.47M | -5.65% | 66,737 | - |
| 273 | YDES | YD Bio Limited | 344.57M | 9.62% | 82,185 | 510.36K |
| 274 | IRD | Opus Genetics, Inc. | 344.01M | 1.60% | 1,014,618 | 9.86M |
| 275 | ABEO | Abeona Therapeutics Inc. | 341.96M | -2.45% | 698,227 | 25.52M |
| 276 | STRO | Sutro Biopharma, Inc. | 340.83M | -6.18% | 64,285 | 45.70M |
| 277 | IMRX | Immuneering Corporation | 339.01M | -1.69% | 257,192 | - |
| 278 | SABS | SAB Biotherapeutics, Inc. | 335.74M | -2.38% | 140,654 | 114.70K |
| 279 | AGEN | Agenus Inc. | 334.73M | -9.99% | 982,230 | 132.69M |
| 280 | VCRE | Vicore Pharma Holding AB (publ) | 331.22M | -3.00% | 188 | 370.61K |
| 281 | PRQR | ProQR Therapeutics N.V. | 330.93M | 5.63% | 1,436,477 | 21.05M |
| 282 | OBIO | Orchestra BioMed Holdings, Inc. | 325.47M | -2.43% | 133,589 | 31.98M |
| 283 | VNDA | Vanda Pharmaceuticals Inc. | 322.87M | -4.13% | 513,638 | 215.72M |
| 284 | RNAC | Cartesian Therapeutics, Inc. | 312.99M | -1.38% | 91,569 | 1.48M |
| 285 | VOGX | Vogenx, Inc. | 307.79M | -4.51% | 88,170 | - |
| 286 | ARCT | Arcturus Therapeutics Holdings Inc. | 304.13M | 4.09% | 1,626,464 | 29.37M |
| 287 | IFRX | InflaRx N.V. | 301.37M | -3.54% | 384,890 | -11.54K |
| 288 | FATE | Fate Therapeutics, Inc. | 295.96M | -6.79% | 720,403 | 6.49M |
| 289 | IVVD | Invivyd, Inc. | 292.75M | 3.51% | 5,585,121 | 58.37M |
| 290 | FULC | Fulcrum Therapeutics, Inc. | 291.84M | -2.17% | 470,409 | 80.00M |
| 291 | BCYC | Bicycle Therapeutics plc | 289.77M | - | 205,665 | 61.21M |
| 292 | AVXL | Anavex Life Sciences Corp. | 288.21M | -8.26% | 326,383 | - |
| 293 | TTRX | Turn Therapeutics Inc. | 287.75M | -1.63% | 18,645 | - |
| 294 | CAMP | Camp4 Therapeutics Corporation | 282.39M | -3.23% | 345,928 | 4.22M |
| 295 | NMRA | Neumora Therapeutics, Inc. | 281.84M | -8.54% | 1,030,852 | - |
| 296 | ELDN | Eledon Pharmaceuticals, Inc. | 281.03M | -2.68% | 296,971 | - |
| 297 | ALXO | ALX Oncology Holdings Inc. | 276.55M | -2.91% | 229,480 | - |
| 298 | ADAG | Adagene Inc. | 274.62M | -0.73% | 136,863 | 9.29M |
| 299 | SRZN | Surrozen, Inc. | 274.09M | -2.87% | 68,754 | 11.51M |
| 300 | LCTX | Lineage Cell Therapeutics, Inc. | 271.88M | -2.27% | 738,404 | 13.08M |
| 301 | WHWK | Whitehawk Therapeutics, Inc. | 270.22M | -2.67% | 205,877 | 7.15M |
| 302 | TRDA | Entrada Therapeutics, Inc. | 267.54M | -4.63% | 102,054 | 4.69M |
| 303 | PYXS | Pyxis Oncology, Inc. | 258.98M | -7.86% | 448,980 | 11.04M |
| 304 | SLGL | Sol-Gel Technologies Ltd. | 258.92M | 0.78% | 21,620 | 1.80M |
| 305 | SION | Sionna Therapeutics, Inc. | 258.16M | -8.64% | 1,077,999 | - |
| 306 | MGNX | MacroGenics, Inc. | 257.35M | -3.12% | 211,489 | 175.14M |
| 307 | ALEC | Alector, Inc. | 256.81M | -5.35% | 335,265 | 13.86M |
| 308 | CNXU | Conexeu Sciences Inc. | 253.40M | 5.69% | 159,693 | - |
| 309 | ACIU | AC Immune SA | 251.55M | -1.94% | 180,978 | 21.67M |
| 310 | NAGE | Niagen Bioscience, Inc. | 248.98M | -0.95% | 251,216 | 129.08M |
| 311 | CGEN | Compugen Ltd. | 247.70M | 7.17% | 617,226 | 74.00M |
| 312 | DTIL | Precision BioSciences, Inc. | 240.13M | 2.35% | 315,578 | 45.06M |
| 313 | CLLS | Cellectis S.A. | 232.55M | 6.31% | 23,734 | 63.82M |
| 314 | ABOS | Acumen Pharmaceuticals, Inc. | 229.25M | 0.63% | 399,170 | - |
| 315 | TARA | Protara Therapeutics, Inc. | 228.11M | -2.53% | 233,616 | - |
| 316 | NERV | Minerva Neurosciences, Inc. | 227.52M | -0.52% | 31,318 | - |
| 317 | RNA | Atrium Therapeutics, Inc. | 226.39M | -3.46% | 123,902 | 35.84M |
| 318 | GLSI | Greenwich LifeSciences, Inc. | 224.43M | -11.82% | 134,997 | - |
| 319 | IMUX | Immunic, Inc. | 221.31M | -1.40% | 68,759 | - |
| 320 | ANTX | AN2 Therapeutics, Inc. | 217.36M | -3.36% | 63,400 | - |
| 321 | ACOG | Alpha Cognition Inc. | 214.58M | 10.85% | 284,160 | 15.26M |
| 322 | PEPG | PepGen Inc. | 214.01M | 1.31% | 764,189 | - |
| 323 | KROS | Keros Therapeutics, Inc. | 213.14M | -3.15% | 74,491 | 15.01M |
| 324 | TNXP | Tonix Pharmaceuticals Holding Corp. | 212.50M | -2.67% | 246,466 | 29.10M |
| 325 | NBP | NovaBridge Biosciences | 212.22M | -7.32% | 311,949 | - |
| 326 | MSLE | Satellos Bioscience Inc. | 208.32M | -1.29% | 9,645 | - |
| 327 | VYGR | Voyager Therapeutics, Inc. | 204.88M | -2.49% | 397,213 | 34.46M |
| 328 | CHRS | Coherus Oncology, Inc. | 199.31M | -3.01% | 444,117 | 50.94M |
| 329 | ORMP | Oramed Pharmaceuticals Inc. | 196.76M | -1.25% | 117,966 | 2.00M |
| 330 | IPHA | Innate Pharma S.A. | 195.33M | -3.21% | 43,390 | 10.57M |
| 331 | PLX | Protalix BioTherapeutics, Inc. | 190.95M | 0.85% | 237,079 | 80.62M |
| 332 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 190.90M | -1.20% | 207,420 | - |
| 333 | KRRO | Korro Bio, Inc. | 189.15M | -7.92% | 33,623 | 2.38M |
| 334 | HUMA | Humacyte, Inc. | 187.21M | -8.30% | 4,713,845 | 2.12M |
| 335 | NGEN | NervGen Pharma Corp. | 181.97M | -2.29% | 154,840 | - |
| 336 | NKTX | Nkarta, Inc. | 175.48M | -3.54% | 395,680 | - |
| 337 | CRBU | Caribou Biosciences, Inc. | 172.07M | -2.13% | 610,665 | 10.04M |
| 338 | CDXS | Codexis, Inc. | 171.92M | -1.88% | 995,480 | 77.68M |
| 339 | CNTN | Canton Strategic Holdings, Inc. | 170.52M | 2.39% | 514,867 | 1.50M |
| 340 | MDWD | MediWound Ltd. | 169.90M | -3.16% | 55,226 | 11.86M |
| 341 | MOLN | Molecular Partners AG | 162.97M | -2.31% | 3,640 | 856.30K |
| 342 | ARMP | Armata Pharmaceuticals, Inc. | 161.00M | -14.60% | 191,078 | 5.54M |
| 343 | OKUR | OnKure Therapeutics, Inc. | 159.76M | -3.31% | 73,595 | - |
| 344 | MENS | Jyong Biotech Ltd. | 159.23M | 3.12% | 29,971 | - |
| 345 | TNYA | Tenaya Therapeutics, Inc. | 155.59M | -2.67% | 1,176,494 | 1.34M |
| 346 | KZIA | Kazia Therapeutics Limited | 154.89M | -3.66% | 68,317 | 1.27M |
| 347 | INDP | Indaptus Therapeutics, Inc. | 154.01M | 44.68% | 9,492,797 | - |
| 348 | UNCY | Unicycive Therapeutics, Inc. | 151.53M | -2.51% | 442,682 | - |
| 349 | TLSA | Tiziana Life Sciences Ltd | 148.55M | 7.36% | 1,450,304 | - |
| 350 | SPRB | Spruce Biosciences, Inc. | 148.07M | -2.72% | 15,245 | 697.00K |
| 351 | CNTB | Connect Biopharma Holdings Limited | 146.10M | -5.69% | 437,486 | 2.95M |
| 352 | MIST | Milestone Pharmaceuticals Inc. | 145.14M | -4.63% | 1,896,113 | 2.34M |
| 353 | LENZ | LENZ Therapeutics, Inc. | 144.53M | -6.50% | 343,705 | 21.48M |
| 354 | NRXP | NRx Pharmaceuticals, Inc. | 144.17M | 3.30% | 568,166 | 3.39M |
| 355 | EQ | Equillium, Inc. | 142.26M | -3.43% | 171,666 | 4.39M |
| 356 | HURA | TuHURA Biosciences, Inc. | 141.38M | -2.63% | 118,296 | - |
| 357 | AARD | Aardvark Therapeutics, Inc. | 132.29M | -10.44% | 175,141 | - |
| 358 | PMN | ProMIS Neurosciences, Inc. | 130.48M | -0.75% | 11,462 | - |
| 359 | INO | Inovio Pharmaceuticals, Inc. | 129.76M | -3.46% | 3,242,088 | 65.34K |
| 360 | CBUS | Cibus, Inc. | 129.55M | -0.29% | 56,398 | 4.35M |
| 361 | OTLK | Outlook Therapeutics, Inc. | 126.99M | -1.59% | 6,279,200 | -1.16M |
| 362 | ANIX | Anixa Biosciences, Inc. | 123.50M | -2.16% | 125,602 | - |
| 363 | BDTX | Black Diamond Therapeutics, Inc. | 121.80M | -3.20% | 792,935 | 70.00M |
| 364 | GNLX | Genelux Corporation | 121.68M | 2.24% | 322,000 | 8.00K |
| 365 | VANI | Vivani Medical, Inc. | 121.48M | 1.35% | 94,968 | - |
| 366 | RANI | Rani Therapeutics Holdings, Inc. | 120.70M | -5.54% | 688,589 | 4.88M |
| 367 | ENGN | enGene Therapeutics Inc. | 118.24M | -4.59% | 212,710 | - |
| 368 | NAUT | Nautilus Biotechnology, Inc. | 116.40M | 1.46% | 349,005 | 190.00K |
| 369 | SEER | Seer, Inc. | 114.62M | 0.98% | 65,126 | 14.22M |
| 370 | COYA | Coya Therapeutics, Inc. | 112.83M | -3.22% | 41,010 | 8.02M |
| 371 | NTHI | NeOnc Technologies Holdings, Inc. | 110.36M | -4.10% | 157,132 | 39.99K |
| 372 | GUTS | Fractyl Health, Inc. | 109.12M | -0.07% | 668,623 | 3.00K |
| 373 | YARW | Yarrow Bioscience, Inc. | 108.07M | -4.94% | 21,897 | - |
| 374 | CUE | Cue Biopharma, Inc. | 107.93M | -2.23% | 95,166 | 37.66M |
| 375 | PLYX | Polaryx Therapeutics, Inc. | 104.18M | -3.24% | 41,129 | - |
| 376 | ONCY | Oncolytics Biotech Inc. | 102.26M | -3.49% | 397,921 | - |
| 377 | PYPD | PolyPid Ltd. | 101.76M | - | 85,035 | - |
| 378 | TENX | Tenax Therapeutics, Inc. | 101.10M | -7.11% | 2,979,849 | - |
| 379 | ACET | Adicet Bio, Inc. | 100.22M | -1.90% | 41,259 | - |
| 380 | BMEA | Biomea Fusion, Inc. | 98.58M | -2.16% | 363,846 | - |
| 381 | ACRV | Acrivon Therapeutics, Inc. | 96.85M | -5.44% | 383,524 | - |
| 382 | KLRS | Kalaris Therapeutics, Inc. | 96.41M | -2.88% | 12,405 | - |
| 383 | ATRA | Atara Biotherapeutics, Inc. | 92.55M | -3.96% | 17,517 | 6.19M |
| 384 | FBIO | Fortress Biotech, Inc. | 92.38M | -2.81% | 215,795 | 68.47M |
| 385 | PTHS | Pelthos Therapeutics Inc. | 92.17M | 2.71% | 19,065 | 43.30M |
| 386 | ALDX | Aldeyra Therapeutics, Inc. | 92.00M | -3.48% | 565,183 | - |
| 387 | ICCC | ImmuCell Corporation | 91.37M | -0.69% | 80,809 | 30.68M |
| 388 | CGTX | Cognition Therapeutics, Inc. | 90.01M | -3.30% | 247,467 | - |
| 389 | RLYB | Rallybio Corporation | 88.47M | -2.00% | 7,114 | 646.00K |
| 390 | GANX | Gain Therapeutics, Inc. | 85.98M | -4.83% | 282,532 | - |
| 391 | MAIA | MAIA Biotechnology, Inc. | 83.64M | -1.08% | 164,423 | - |
| 392 | VRCA | Verrica Pharmaceuticals Inc. | 83.32M | -2.81% | 119,936 | 30.32M |
| 393 | ELTX | Elicio Therapeutics, Inc. | 80.16M | -2.56% | 134,090 | - |
| 394 | OKYO | OKYO Pharma Limited | 78.93M | -0.39% | 9,206 | - |
| 395 | TELO | Telomir Pharmaceuticals, Inc. | 78.75M | -2.14% | 18,565 | - |
| 396 | NRXS | NeurAxis, Inc. | 77.54M | -3.21% | 31,024 | 5.32M |
| 397 | ATHE | Alterity Therapeutics Limited | 77.43M | -8.12% | 18,980 | 4.43M |
| 398 | GOSS | Gossamer Bio, Inc. | 76.68M | 0.16% | 5,088,354 | 53.29M |
| 399 | ANVS | Annovis Bio, Inc. | 76.36M | -2.97% | 443,066 | - |
| 400 | ELOX | Eloxx Pharmaceuticals, Inc. | 75.89M | 3.55% | 29,617 | - |
| 401 | LONA | LeonaBio, Inc. | 74.49M | 1.28% | 7,521 | - |
| 402 | CING | Cingulate Inc. | 74.02M | -3.42% | 84,772 | - |
| 403 | DWTX | Dogwood Therapeutics, Inc. | 73.08M | -6.93% | 25,327 | - |
| 404 | IBIO | iBio, Inc. | 72.53M | -2.01% | 1,620,533 | 300.00K |
| 405 | PMVP | PMV Pharmaceuticals, Inc. | 70.93M | 3.91% | 383,761 | - |
| 406 | SPRO | Spero Therapeutics, Inc. | 70.76M | -1.22% | 487,932 | 47.00M |
| 407 | PLRX | Pliant Therapeutics, Inc. | 70.28M | -2.99% | 220,126 | - |
| 408 | XBIT | XBiotech Inc. | 70.12M | -0.43% | 2,327 | - |
| 409 | CRDF | Cardiff Oncology, Inc. | 69.81M | -0.06% | 394,381 | 508.00K |
| 410 | SER | Serina Therapeutics, Inc. | 68.45M | -0.92% | 11,582 | 130.00K |
| 411 | OSTX | OS Therapies Incorporated | 68.37M | 5.14% | 254,931 | - |
| 412 | RNTX | Rein Therapeutics Inc. | 68.28M | 0.78% | 2,020,782 | - |
| 413 | MNOV | MediciNova, Inc. | 67.19M | -1.09% | 19,390 | 920.48K |
| 414 | CSBR | Champions Oncology, Inc. | 66.97M | -2.43% | 1,645 | 59.43M |
| 415 | BOLD | Boundless Bio, Inc. | 65.96M | 1.40% | 181,316 | - |
| 416 | BSEM | BioStem Technologies, Inc. | 65.51M | 9.72% | 127,599 | 34.59M |
| 417 | IMA | ImageneBio, Inc. | 65.04M | 0.70% | 1,899 | 800.00K |
| 418 | HYFT | MindWalk Holdings Corp. | 64.84M | -4.83% | 50,635 | 11.43M |
| 419 | EXOZ | eXoZymes, Inc. | 62.04M | 6.41% | 9,732 | -700.00 |
| 420 | INMB | INmune Bio Inc. | 60.78M | -1.79% | 288,816 | 50.00K |
| 421 | RNXT | RenovoRx, Inc. | 60.47M | 1.90% | 200,687 | 1.98M |
| 422 | XLO | Xilio Therapeutics, Inc. | 59.95M | -3.19% | 5,837 | 64.09M |
| 423 | HRTX | Heron Therapeutics, Inc. | 57.18M | -4.35% | 1,408,828 | 151.18M |
| 424 | INKT | MiNK Therapeutics, Inc. | 56.89M | 2.61% | 8,868 | - |
| 425 | IMMP | Immutep Limited | 56.65M | -0.15% | 60,089 | 5.28M |
| 426 | TCRX | TScan Therapeutics, Inc. | 52.61M | 3.49% | 291,790 | 7.11M |
| 427 | APLM | Apollomics, Inc. | 51.39M | -0.81% | 4,649 | 8.84M |
| 428 | TIL | Instil Bio, Inc. | 50.66M | 1.08% | 1,651 | - |
| 429 | ATYR | aTyr Pharma, Inc. | 49.22M | -5.82% | 628,836 | 190.00K |
| 430 | VRXA | Veraxa Biotech AG | 48.17M | 2.69% | 28,160 | - |
| 431 | HYPD | Hyperion DeFi, Inc. | 48.02M | 1.64% | 918,726 | 1.40M |
| 432 | MREO | Mereo BioPharma Group plc | 47.91M | -3.69% | 584,489 | 500.00K |
| 433 | IBO | Impact BioMedical Inc. | 47.67M | 2.05% | 5,596 | 35.00K |
| 434 | CNTX | Context Therapeutics Inc. | 46.68M | 4.23% | 1,229,565 | - |
| 435 | MGX | Metagenomi Therapeutics, Inc. | 45.52M | -2.82% | 96,296 | 13.56M |
| 436 | MCRB | Seres Therapeutics, Inc. | 45.33M | -2.56% | 38,716 | 1.88M |
| 437 | GRCE | Grace Therapeutics, Inc. | 44.81M | -3.18% | 47,252 | - |
| 438 | FLNA | Filana Therapeutics, Inc. | 44.71M | -4.20% | 131,360 | - |
| 439 | ALPS | Alps Group Inc | 44.26M | -1.48% | 111,679 | 3.74M |
| 440 | EDSA | Edesa Biotech, Inc. | 43.93M | -20.70% | 286,723 | - |
| 441 | VERU | Veru Inc. | 43.65M | -3.03% | 97,490 | 16.89M |
| 442 | NTRB | Nutriband Inc. | 42.79M | -0.85% | 3,164 | 1.80M |
| 443 | KPTI | Karyopharm Therapeutics Inc. | 42.19M | -7.00% | 467,986 | 146.62M |
| 444 | ALGS | Aligos Therapeutics, Inc. | 39.93M | -7.18% | 35,854 | 31.52M |
| 445 | CRVO | CervoMed Inc. | 39.01M | -4.80% | 211,366 | 331.30K |
| 446 | BCTX | BriaCell Therapeutics Corp. | 34.31M | 2.53% | 230,169 | - |
| 447 | ATNM | Actinium Pharmaceuticals, Inc. | 34.28M | -3.50% | 90,726 | 35.09M |
| 448 | LITS | Lite Strategy, Inc. | 32.67M | 2.15% | 168,826 | - |
| 449 | QNCX | Quince Therapeutics, Inc. | 32.65M | -3.41% | 18,935 | - |
| 450 | ESLA | Estrella Immunopharma, Inc. | 31.85M | 0.45% | 11,703 | - |
| 451 | RADX | Radiopharm Theranostics Limited | 30.88M | -7.80% | 83,167 | 10.86M |
| 452 | BYSI | BeyondSpring Inc. | 29.96M | 0.91% | 24,104 | 1.88M |
| 453 | NNVC | NanoViricides, Inc. | 29.84M | -2.24% | 157,801 | - |
| 454 | NXTC | NextCure, Inc. | 29.18M | -5.97% | 63,995 | - |
| 455 | KYNB | Kyntra Bio, Inc. | 28.95M | - | 10,313 | 4.62M |
| 456 | LTRN | Lantern Pharma Inc. | 28.89M | -9.24% | 110,290 | - |
| 457 | IGC | IGC Pharma, Inc. | 28.60M | -3.03% | 528,739 | 1.11M |
| 458 | GNTA | Genenta Science S.p.A. | 28.55M | -0.82% | 28,270 | - |
| 459 | ACTU | Actuate Therapeutics, Inc. | 27.99M | 10.38% | 537,964 | - |
| 460 | TVGN | Tevogen Inc. | 26.73M | -1.32% | 545 | - |
| 461 | GRDX | GridAI Technologies Corp. | 26.52M | -2.73% | 89,331 | - |
| 462 | LGVN | Longeveron Inc. | 26.46M | 0.94% | 571,330 | 1.19M |
| 463 | EVAX | Evaxion A/S | 26.27M | - | 3,415,142 | 7.49M |
| 464 | ENLV | Enlivex Ltd. | 26.23M | -13.29% | 236,483 | - |
| 465 | DYAI | Dyadic International, Inc. | 25.65M | -4.74% | 40,822 | 3.80M |
| 466 | CVM | CEL-SCI Corporation | 25.43M | -11.28% | 165,886 | - |
| 467 | BRNS | Barinthus Biotherapeutics plc | 25.17M | 2.31% | 1,059 | 14.97M |
| 468 | ATOS | Atossa Therapeutics, Inc. | 25.05M | -4.92% | 63,385 | - |
| 469 | ALLR | Allarity Therapeutics, Inc. | 23.55M | 3.50% | 74,112 | 345.00K |
| 470 | JSPR | Jasper Therapeutics, Inc. | 23.36M | -5.76% | 2,269,582 | - |
| 471 | CELU | Celularity Inc. | 23.15M | 2.81% | 32,697 | 26.55M |
| 472 | ABVC | ABVC BioPharma, Inc. | 23.02M | -5.18% | 63,723 | 797.92K |
| 473 | QNTM | Quantum BioPharma Ltd. | 22.22M | -1.70% | 115,200 | - |
| 474 | COCP | Cocrystal Pharma, Inc. | 21.96M | -0.44% | 146,871 | 330.00K |
| 475 | MRKR | Marker Therapeutics, Inc. | 21.45M | -0.29% | 75,891 | 2.69M |
| 476 | NEUP | Neuphoria Therapeutics Inc. | 21.24M | - | 28,744 | -13.27K |
| 477 | CNSY | Cerenome, Inc. | 21.06M | -4.08% | 37,510 | 4.20M |
| 478 | HOWL | Werewolf Therapeutics, Inc. | 20.79M | 4.50% | 167,763 | 21.00M |
| 479 | CLRB | Cellectar Biosciences, Inc. | 20.26M | -3.24% | 28,432 | - |
| 480 | PLRZ | Polyrizon Ltd. | 19.88M | -5.09% | 62,605 | - |
| 481 | CALC | CalciMedica, Inc. | 19.59M | -6.39% | 984,567 | - |
| 482 | CYCN | Cyclerion Therapeutics, Inc. | 19.58M | 2.91% | 80,123 | 1.90M |
| 483 | LEXX | Lexaria Bioscience Corp. | 19.17M | 0.78% | 61,248 | 194.00K |
| 484 | PTN | Palatin Technologies, Inc. | 19.04M | 0.98% | 7,033 | 12.88M |
| 485 | PLUR | Pluri Inc. | 18.77M | -1.14% | 14,156 | 1.08M |
| 486 | NCEL | NewcelX Ltd. | 18.01M | 2.92% | 8,737 | - |
| 487 | TVRD | Tvardi Therapeutics, Inc. | 17.21M | -2.39% | 85,393 | - |
| 488 | LPCN | Lipocine Inc. | 16.98M | 0.49% | 9,267 | 1.57M |
| 489 | TPST | Tempest Therapeutics, Inc. | 16.30M | -4.67% | 75,107 | - |
| 490 | CTXR | Citius Pharmaceuticals, Inc. | 16.28M | -7.00% | 401,058 | 7.11M |
| 491 | KTTA | Pasithea Therapeutics Corp. | 15.93M | -2.69% | 63,342 | - |
| 492 | HIND | Vyome Holdings, Inc. | 15.72M | -3.45% | 7,944 | 129.73K |
| 493 | KALA | KALA BIO, Inc. | 15.56M | -6.98% | 53,968 | - |
| 494 | AKTX | Akari Therapeutics, Plc | 15.37M | -0.06% | 15,094 | - |
| 495 | PBM | Psyence Biomedical Ltd. | 14.88M | -4.88% | 43,164 | - |
| 496 | INTS | Intensity Therapeutics, Inc. | 14.86M | 8.33% | 24,945 | - |
| 497 | CMMB | Chemomab Therapeutics Ltd. | 14.69M | -2.39% | 59,850 | - |
| 498 | MLEC | Moolec Science SA | 14.67M | 1.44% | 1,951 | 7.83M |
| 499 | PASG | Passage Bio, Inc. | 14.64M | 0.89% | 5,589 | - |
| 500 | ICU | SeaStar Medical Holding Corporation | 14.59M | 1.22% | 43,264 | 1.71M |